News

A new drug has been developed to treat a severe hereditary muscle disease, and may also help those with statin-related myopathy.

A new study has found that both combined and progesterone-only hormonal contraceptives are associated with a similar relative increase in breast cancer risk of around 20–30%.

By using nanotechnology to repair the pumping action of lymphatic vessels, Georgia Institute of Technology researchers have developed a unique approach to treating lymphedema.

Researchers have developed and used an upgraded tumor model that mimics bone to find that the body’s immune response can make tumor cells more resistant to chemotherapy.

A new substance has proven useful for treating staphylococcus infections in people with skin lymphoma. This is good news for the patients, but also for the global threat of antibiotic resistance.

University of Wyoming researchers’ study of how microscopic creatures called tardigrades survive extreme conditions has led to a major breakthrough that could eventually make life-saving treatments available to people where refrigeration isn’t possible.

After monitoring for several years, scientists have detected the emergence of extensively drug-resistant strains of Shigella sonnei in France.

Genes that are well-known for controlling the formation of bones before birth also play a key role in bone healing later in life, according to a new study.

A new study reveals the mechanisms responsible for the development of tumor resistance to a new drug, the first approved inhibitor against the KRAS oncogene.

A targeted therapy that combines two different drugs has been shown to be effective at reducing the size and number of non-small cell lung cancer tumors in mice.